Data Digests
Stay current with concise, clinically relevant synopses of key data from clinical research and real-world studies. Digests highlight key findings, clinical implications, and areas for ongoing investigation.
This randomized clinical trial investigated the relative effectiveness and safety of three common treatment approaches for major depressive disorder (MDD) in patients who did not adequately respond to their initial antidepressant treatment. The study aimed to assess the effects of three next-step treatment strategies, including switching to a norepinephrine/dopamine-reuptake inhibitor (NDRI), augmenting with an NDRI, or augmenting with an atypical antipsychotic.
Learn More.webp?language=en-US)